SureTrader SureTrader
Home > Boards > US OTC > Biotechs > OncoSec Medical Inc. (ONCS)

;)

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Vulcan4 Member Profile
 
Followed By 75
Posts 3,689
Boards Moderated 0
Alias Born 10/24/13
160x600 placeholder
OncoSec to Present at the 9th Annual LD Micro Main Event "PR Newswire (US)" - 12/1/2016 6:01:00 AM
OncoSec Announces Key Corporate Initiatives at Inaugural Investor & Analyst Day on November 17, 2016 "PR Newswire (US)" - 11/17/2016 6:01:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) "Edgar (US Regulatory)" - 11/16/2016 6:59:20 AM
Tender Offer Statement by Issuer (sc To-i) "Edgar (US Regulatory)" - 11/16/2016 6:55:55 AM
OncoSec to Host First Quarter Financial Results Conference Call on December 8, 2016 "PR Newswire (US)" - 11/15/2016 6:01:00 AM
OncoSec Presents Positive Interim Response Data at the Society for Immunotherapy of Cancer (SITC) Annual Meeting 2016 "PR Newswire (US)" - 11/11/2016 1:01:00 PM
OncoSec Announces Positive Interim Response Data at the Society for Immunotherapy of Cancer (SITC) Annual Meeting 2016 "PR Newswire (US)" - 11/8/2016 8:01:00 AM
OncoSec to Present at Scientific and Investment Conferences and to Host Inaugural Investor and Analyst Day in November "PR Newswire (US)" - 11/1/2016 6:01:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) "Edgar (US Regulatory)" - 10/27/2016 6:09:26 AM
Proxy Statement (definitive) (def 14a) "Edgar (US Regulatory)" - 10/27/2016 6:07:02 AM
OncoSec to Host Investor & Analyst Day on November 17, 2016 Spotlighting Industry-Leading Intratumoral Immunotherapy Pipeline... "PR Newswire (US)" - 10/18/2016 6:01:00 AM
Annual Report (10-k) "Edgar (US Regulatory)" - 10/13/2016 4:10:29 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/13/2016 4:03:10 PM
OncoSec Announces Fourth Quarter and Year End Results for Fiscal Year 2016 "PR Newswire (US)" - 10/13/2016 4:01:00 PM
OncoSec Announces Acceptance of Late Breaking Abstract at Upcoming Society for Immunotherapy of Cancer (SITC) Annual Meeting ... "PR Newswire (US)" - 10/13/2016 6:01:00 AM
OncoSec to Present at Scientific and Investment Conferences in October "PR Newswire (US)" - 10/10/2016 6:00:00 AM
OncoSec to Host Fourth Quarter and Fiscal Year End Financial Results Conference Call on October 13, 2016 "PR Newswire (US)" - 9/30/2016 6:01:00 AM
Initial Statement of Beneficial Ownership (3) "Edgar (US Regulatory)" - 9/6/2016 9:01:17 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/6/2016 6:17:03 AM
OncoSec Appoints Sharron Gargosky, PhD, to Chief Clinical and Regulatory Officer "PR Newswire (US)" - 9/6/2016 6:00:00 AM
OncoSec to Present at Scientific and Investment Conferences in September "PR Newswire (US)" - 9/1/2016 6:00:00 AM
Notice of Effectiveness (effect) "Edgar (US Regulatory)" - 8/26/2016 6:02:13 AM
Securities Registration Statement (simplified Form) (s-3/a) "Edgar (US Regulatory)" - 8/23/2016 4:21:43 PM
OncoSec Announces Peer-Reviewed Publication of T-Cell Exhaustion Marker to Predict Response to Anti-PD-1 Therapy in Melanoma "PR Newswire (US)" - 8/15/2016 4:01:00 PM
Securities Registration Statement (simplified Form) (s-3) "Edgar (US Regulatory)" - 8/9/2016 5:27:03 PM
Vulcan4   Tuesday, 12/24/13 03:30:05 PM
Re: DDJ post# 6497
Post # of 37822 
;)

I'm wit ya, man.. :)

SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist